Assertio Holdings Inc
ASRT0.720USD
+0.008+1.15%
收盘 12/19, 16:00（美东）报价延迟15分钟
69.30M总市值
亏损市盈率 TTM
关于 Assertio Holdings Inc 公司
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Assertio Holdings Inc简介
公司代码ASRT
公司名称Assertio Holdings Inc
上市日期Feb 12, 1997
CEOReisenauer (Mark L)
员工数量58
证券类型Ordinary Share
年结日Feb 12
公司地址100 S. Saunders Road
城市LAKE FOREST
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60045
电话12244197106
网址https://www.assertiotx.com/
公司代码ASRT
上市日期Feb 12, 1997
CEOReisenauer (Mark L)
Assertio Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
98.54K
-8.33%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
Ms. Mary E Pietryga
Ms. Mary E Pietryga
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
98.54K
-8.33%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
地区USD
名称
营收
占比
United States
29.22M
100.00%
业务
地区
业务USD
名称
营收
占比
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
股东统计
更新时间: 11月8日 周六
更新时间: 11月8日 周六
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.60%
Renaissance Technologies LLC
3.06%
BlackRock Institutional Trust Company, N.A.
1.42%
Geode Capital Management, L.L.C.
1.06%
其他
80.71%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.60%
Renaissance Technologies LLC
3.06%
BlackRock Institutional Trust Company, N.A.
1.42%
Geode Capital Management, L.L.C.
1.06%
其他
80.71%
股东类型
持股股东
占比
Hedge Fund
14.41%
Investment Advisor
9.48%
Investment Advisor/Hedge Fund
3.17%
Individual Investor
2.60%
Research Firm
0.09%
其他
70.25%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
224
26.13M
41.62%
--
2025Q3
272
26.13M
50.34%
+166.65K
2025Q2
302
25.96M
57.74%
-170.79K
2025Q1
322
26.13M
60.78%
-32.08M
2024Q4
324
28.59M
62.27%
-1.80M
2024Q3
317
30.58M
67.93%
-6.52M
2024Q2
313
38.50M
75.68%
-8.13M
2024Q1
304
45.57M
70.80%
-21.77M
2023Q4
296
48.05M
61.35%
+410.44K
2023Q3
284
47.86M
41.05%
+12.38M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
8.81M
9.15%
+370.31K
+4.39%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
4.56%
--
--
Jun 30, 2025
Renaissance Technologies LLC
2.82M
2.93%
+117.69K
+4.35%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
1.43%
-11.56K
-0.83%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.06%
-86.31K
-7.79%
Jun 30, 2025
Two Sigma Investments, LP
867.90K
0.9%
-357.19K
-29.16%
Jun 30, 2025
CM Management, LLC
724.38K
0.75%
+249.38K
+52.50%
Jun 30, 2025
Polen Capital Management, LLC
651.61K
0.68%
-129.46K
-16.57%
Sep 30, 2024
Peisert (Daniel A)
607.46K
0.63%
--
--
Mar 13, 2025
Millennium Management LLC
694.52K
0.72%
-90.05K
-11.48%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ALPS Barron's 400 ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Royce Quant Small-Cap Quality Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Fidelity Small-Mid Multifactor ETF
0%
iShares Russell 3000 ETF
0%
查看更多
ALPS Barron's 400 ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
iShares Russell 2000 ETF
占比0%
Global X Russell 2000 ETF
占比0%
Royce Quant Small-Cap Quality Value ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
Proshares Ultra Russell 2000
占比0%
Lattice Hartford Multifactor Small Cap ETF
占比0%
Fidelity Small-Mid Multifactor ETF
占比0%
iShares Russell 3000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
公告日期
类型
比率
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
常见问题
Assertio Holdings Inc的前五大股东是谁？
Assertio Holdings Inc 的前五大股东如下：
Nantahala Capital Management, LLC持有股份：8.81M，占总股份比例：9.15%。
The Vanguard Group, Inc.持有股份：4.38M，占总股份比例：4.56%。
Renaissance Technologies LLC持有股份：2.82M，占总股份比例：2.93%。
BlackRock Institutional Trust Company, N.A.持有股份：1.37M，占总股份比例：1.43%。
Geode Capital Management, L.L.C.持有股份：1.02M，占总股份比例：1.06%。
Nantahala Capital Management, LLC持有股份：8.81M，占总股份比例：9.15%。
The Vanguard Group, Inc.持有股份：4.38M，占总股份比例：4.56%。
Renaissance Technologies LLC持有股份：2.82M，占总股份比例：2.93%。
BlackRock Institutional Trust Company, N.A.持有股份：1.37M，占总股份比例：1.43%。
Geode Capital Management, L.L.C.持有股份：1.02M，占总股份比例：1.06%。
Assertio Holdings Inc的前三大股东类型是什么？
Assertio Holdings Inc 的前三大股东类型分别是：
Nantahala Capital Management, LLC
The Vanguard Group, Inc.
Renaissance Technologies LLC
Nantahala Capital Management, LLC
The Vanguard Group, Inc.
Renaissance Technologies LLC
有多少机构持有Assertio Holdings Inc(ASRT)的股份？
截至2025Q4，共有224家机构持有Assertio Holdings Inc的股份，合计持有的股份价值约为26.13M，占公司总股份的41.62%。与2025Q3相比，机构持股有所增加，增幅为-8.72%。
哪个业务部门对Assertio Holdings Inc的收入贡献最大？
在FY2025Q2，ROLVEDON业务部门对Assertio Holdings Inc的收入贡献最大，创收16.13M，占总收入的55.19%。
